Empresa Jaguar Health Inc Nasdaq
Acciones
US47008L1061
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Health
98,2
%
| 12 | 98,2 % | 10 | 98,2 % | -18,34 % |
Animal Health
1,8
%
| 0 | 1,8 % | 0 | 1,8 % | -19,53 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 12 | 100,0 % | 10 | 100,0 % | -18,36 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 01/05/19 |
Chief Tech/Sci/R&D Officer | 60 | 01/05/17 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 01/11/18 |
Chief Tech/Sci/R&D Officer | 62 | 01/05/21 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 09/09/21 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/06/13 |
James Bochnowski
CHM | Chairman | 80 | 01/02/14 |
John Micek
BRD | Director/Board Member | 71 | 01/04/16 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 29/03/18 |
Director/Board Member | 67 | 01/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 9 | 0 | 0 | 92,62 % |
Acción B | 1 | 293 353 560 | 271 699 611 ( 92,62 %) | 0 |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,58 % | 115 mil M | |
+12,41 % | 107 mil M | |
-3,49 % | 21,6 mil M | |
-12,38 % | 22,31 mil M | |
-6,45 % | 19,19 mil M | |
-3,35 % | 18,23 mil M | |
-38,57 % | 17,62 mil M | |
+7,51 % | 14,26 mil M | |
+35,67 % | 12,37 mil M |